Tnf Alpha Protein Tumor Necrosis Factor is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The TNFA protein is encoded by the TNF gene and is implicated in neurodegenerative disease pathogenesis.
TNF-α is synthesized as a 26 kDa transmembrane precursor (pro-TNF) that is cleaved by TACE (TNF-α converting enzyme, also known as ADAM17) to release the mature 17 kDa soluble cytokine. The active form is a stable homotrimer that engages two distinct receptors: TNFR1 (p55, TNFRSF1A) and TNFR2 (p75, TNFRSF1B).
TNF-α is a master regulator of inflammation and cell survival. TNFR1 is expressed ubiquitously and contains a death domain that can trigger apoptosis or necroptosis. TNFR2 is expressed primarily on immune cells and endothelial cells, promoting cell survival and proliferation through NF-κB signaling. In the CNS, TNF is produced by microglia, astrocytes, and neurons, where it regulates synaptic plasticity, sleep, and feeding behavior.
TNF is a central mediator of neuroinflammation in AD, PD, MS, and ALS. In AD, TNF promotes amyloid-beta production, enhances excitotoxicity, and contributes to synaptic dysfunction. In PD, TNF from activated microglia induces dopaminergic neuron death. Elevated CSF TNF levels correlate with disease severity in MS and ALS. TNF polymorphisms affect disease risk and progression.
TNF inhibitors are widely used in autoimmune diseases (RA, IBD, psoriasis). For neurodegenerative diseases, strategies include: (1) anti-TNF antibodies (etanercept, infliximab, adalimumab); (2) TNF receptor-Fc fusion proteins; (3) small molecule TACE inhibitors to block TNF release; (4) blood-brain barrier penetrating anti-TNF compounds. Some clinical trials have shown benefit in AD and PD.
Mouse models with TNF knockout or transgenic expression have been developed to study disease mechanisms.
Current research focuses on:
TNF signaling involves complex downstream pathways:
TNF signals through two distinct receptors:
The study of Tnf Alpha Protein Tumor Necrosis Factor has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.